IPO - Profile

Aesther Healthcare Acquisition Corp.

Finance > Banks

AEHAU

Summary

Offer Price Offer Size 3-Year Outlook Volatility First Day Turnover
$10.00 10,000,000 Positive High 0%

Offering Team

  • Legal counsel
  • Schiff Hardin LLP
  • Auditors
  • Malone & Bailey LLP

Deal Highlights

We are a newly-organized blank check company incorporated in June 2021 as a Delaware corporation whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to as our initial business combination. To date, our efforts have been limited to organizational activities as well as activities related to this offering. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. While we may pursue an initial business combination opportunity in any business, industry, sector or geographical location, we intend to focus on industries that complement our management team’s background and to capitalize on the ability of our management team to identify and acquire a business focusing on the pharmaceutical sector where our management team has extensive experience. Our management team is led by Suren Ajjarapu, our Chairman of the Board and Chief Executive Officer, and Howard A. Doss, our Chief Financial Officer. Mr. Ajjarapu has served as our Chairman and Chief Executive Officer since our inception in June 2021. He has served as the Chairman of the Board, Chief Executive Officer and Secretary of TRxADE Health, Inc., formerly Trxade Group, Inc. (NASDAQ:MEDS)(“TRxADE”) since its acquisition of Trxade Group, Inc., a Nevada corporation (“Trxade Nevada”) (our predecessor company) on January 8, 2014, and as the Chairman of the Board, Chief Executive Officer and Secretary of Trxade Nevada since its inception. Since March 2021, Mr. Ajjarapu has served on the Board of OceanTech Acquisitions I Corp, a Special Purpose Acquisition Company (SPAC)(NASDAQ:OTECU). Mr. Ajjarapu has served on the Board of Kano Energy, Inc, a private company, which is involved in developing renewable natural gas sites in USA since 2018. Mr. Ajjarapu was a Founder, CEO and Chairman of Sansur Renewable Energy, Inc., a company involved in developing wind power sites in the Midwest, United States, from 2009 to 2012. Mr. Ajjarapu was a Founder, President and Director of Aemetis, Inc., a biofuels company (AMTX.OB) and a Founder, Chairman and Chief Executive Officer of International Biofuels, a subsidiary of Aemetis, Inc., from 2006 to 2009. Mr. Ajjarapu was Co-Founder, COO, and Director Global Information Technology, Inc., an IT outsourcing and systems design company, headquartered in Tampa, Florida with major operations in India from 1995 to 2006. Mr. Ajjarapu holds an MS in Environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in International Finance and Management. Mr. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Deal Tracker

IPO Dates

Filing 14 Sep, 2021

Offer 15 Sep, 2021

Look Ahead

Lock Up Expiry Mar 15, 2022

IPO Terms

Offer Price $10.00
Offer Size 10M

Market Sentiments

Stock Price